Paul Ruff to Incidence
This is a "connection" page, showing publications Paul Ruff has written about Incidence.
Connection Strength
0,064
-
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer. Gynecol Oncol. 2020 10; 159(1):142-149.
Score: 0,038
-
Establishment of a cancer surveillance programme: the South African experience. Lancet Oncol. 2015 Aug; 16(8):e414-21.
Score: 0,027